Sinovac Biotech, OverviewSinovac Biotech, EBIT
EBIT (Earnings Before Interest and Taxes) analysis for SVA.
Quarterly EBIT
-$123.05M
↑ 88.59% YoY
As of Dec 31, 2023
Annual EBIT (TTM)
-$1.02B
↓ 105.71% YoY
Trailing 12 months ending Dec 31, 2023
Sinovac Biotech, OverviewEBIT (Earnings Before Interest and Taxes) analysis for SVA.
As of Dec 31, 2023
Trailing 12 months ending Dec 31, 2023